Literature DB >> 27301463

Dysbiosis in the Pathophysiology of Coronary Artery Disease.

Junichiro Irie1, Hiroshi Itoh.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27301463      PMCID： PMC7399293          DOI： 10.5551/jat.ED052

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  9 in total

1.  Distribution of the N-oxidation of dietary-derived trimethylamine in a male Chinese population.

Authors:  C W Lee; B Tomlinson; J H Yeung; G Lin; L A Damani
Journal:  Pharmacogenetics       Date:  2000-12

Review 2.  Changes in coronary heart disease risk among Japanese.

Authors:  Hiroyasu Iso
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

3.  Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.

Authors:  Ayumi Yoshifuji; Shu Wakino; Junichiro Irie; Takaya Tajima; Kazuhiro Hasegawa; Takeshi Kanda; Hirobumi Tokuyama; Koichi Hayashi; Hiroshi Itoh
Journal:  Nephrol Dial Transplant       Date:  2015-10-20       Impact factor: 5.992

4.  Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota.

Authors:  Jan-Hendrik Hehemann; Gaëlle Correc; Tristan Barbeyron; William Helbert; Mirjam Czjzek; Gurvan Michel
Journal:  Nature       Date:  2010-04-08       Impact factor: 49.962

5.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

6.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

Authors:  Weifei Zhu; Jill C Gregory; Elin Org; Jennifer A Buffa; Nilaksh Gupta; Zeneng Wang; Lin Li; Xiaoming Fu; Yuping Wu; Margarete Mehrabian; R Balfour Sartor; Thomas M McIntyre; Roy L Silverstein; W H Wilson Tang; Joseph A DiDonato; J Mark Brown; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

7.  Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease.

Authors:  Takuo Emoto; Tomoya Yamashita; Naoto Sasaki; Yushi Hirota; Tomohiro Hayashi; Anna So; Kazuyuki Kasahara; Keiko Yodoi; Takuya Matsumoto; Taiji Mizoguchi; Wataru Ogawa; Ken-Ichi Hirata
Journal:  J Atheroscler Thromb       Date:  2016-03-05       Impact factor: 4.928

Review 8.  Gut microbiota metabolism of L-carnitine and cardiovascular risk.

Authors:  John R Ussher; Gary D Lopaschuk; Arduino Arduini
Journal:  Atherosclerosis       Date:  2013-10-24       Impact factor: 5.162

Review 9.  Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.

Authors:  Jane F Ferguson; Hooman Allayee; Robert E Gerszten; Folami Ideraabdullah; Penny M Kris-Etherton; José M Ordovás; Eric B Rimm; Thomas J Wang; Brian J Bennett
Journal:  Circ Cardiovasc Genet       Date:  2016-04-19
  9 in total
  1 in total

Review 1.  Understanding the Role of SERCA2a Microdomain Remodeling in Heart Failure Induced by Obesity and Type 2 Diabetes.

Authors:  Ping Lai; Viacheslav O Nikolaev; Kirstie A De Jong
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.